Navigation Links
Sunrise Files 2006 Form 10-K
Date:3/24/2008

estated revenue amounts is due to the reduction in reimbursable contract services revenue as part of the restatement, for which there is an offsetting reduction in expense. Restated net income for 2005 totaled $87.1 million, or $1.82 per fully diluted share, as compared to the $79.7 million, or $1.67 per fully diluted share, that the Company previously reported. Restated net income for 2004 totaled $1.1 million, or $0.03 per fully diluted share, as compared to the $50.7 million, or $1.12 per fully diluted share, that the Company previously reported.

For 2006, the Company reported revenues of $1,648 million and net income of $20.4 million, or $0.40 per fully diluted share.

"The Board is pleased that the restatement is now complete," said Lynn Krominga, Chairman of the Board. "We appreciate the collaborative efforts of the NYSE staff, particularly over the past several days, which have enabled our stock to continue uninterrupted trading. Today's filing, and our recently announced corporate governance changes, significantly advance our efforts to create value for our shareholders."

"The restatement has been a complex and demanding task, and I want to thank all our team members who have tirelessly dedicated their time and efforts," said Paul Klaassen, founder and chief executive officer of Sunrise. "I also want to thank our shareholders, capital partners and lenders for their consistent support, which has allowed us to maintain and expand our business during this time. Now that our restatement is complete, we have a solid foundation on which to move forward with our business. With our recently- announced enhanced corporate governance, continued growth and reputation for championing quality of life for seniors and their families, we believe Sunrise is well positioned for the future."

"Today's filing of the 2006 Form 10-K and completion of the accounting restatement are significant steps towards becoming a current filer," said Rick Nadeau, chie
'/>"/>

SOURCE Sunrise Senior Living, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Sunrise Senior Living Names Mark Ordan Chief Investment and Administrative Officer
2. Sunrise Announces NYSE Deadline Extended
3. Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K
4. Sunrise Reports Preliminary Selected Financial and Operating Data for Fourth-Quarter 2007
5. Sunrise Announces Release Date for Fourth-Quarter Preliminary Selected Financial and Operating Data
6. Sunrise to Unveil New Residence for Seniors at Clayton on the Park
7. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
8. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
9. Sunrise Senior Living Opens First Custom-Built Community for Early, Mid and Late Stage Alzheimers Care Programs
10. Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007
11. Eclipsys Sunrise Acute Care Receives CCHIT Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... According to a recent report by ... break into the surgical robotics market may ... the MIS field dominated by Intuitive. These companies are ... robotics market by 2020. , “The MIS robotic ... CEO and President of iData. “System sales for the ...
(Date:11/27/2014)... Blood-borne pathogens raise the risk of spreading ... in place to counter this. However, it doesn’t seem ... with menstrual blood are taken as seriously. , ... way to handle tampons and menstrual pads while also ... , He then created a prototype of the Sani-M, ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. 26, 2014 ... a second language, new research suggests. But anyone who tries ... brain boost, the small study finds. The brain ... Ping Li, co-director of the Center for Brain, Behavior and ... Li said, that "the brain networks of the more successful ...
(Date:11/27/2014)... In order to enable people to adapt to ... easy way to avoid touching a toilet seat and/or lid ... prototype of the patent-pending Toilet Tamer, a device that enables ... lid in a more sanitary manner. It avoids direct contact ... it promotes good hygiene and peace of mind. The portable ...
(Date:11/27/2014)... 27, 2014 Tylenol lawsuits ( http://www.tylenollawsuitcenter.com/ ... injured by the medication are continuing to move forward ... looking ahead to a status conference in December, Bernstein ... Order issued earlier this year, a conference in the ... 10:00 a.m. Items likely to be discussed at the ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3
... with manufacturing, unreliable delivery of the drug , , FRIDAY, ... the drug rotigotine help relieve restless legs syndrome (RLS), ... drugs -- which stimulate the body,s dopamine system -- ... and rotigotine is already used to treat Parkinson,s disease. ...
... Appeal Action, EXTON, Pa., May 30 Isolagen(TM), ... it received notice from the staff,of the American Stock ... plan of compliance did not demonstrate its ability,to regain ... Sections 1003 (a)(i)-(iii) of the AMEX Company Guide within ...
... The following is being issued,by the Federation of Clinical ... from 58 countries across the globe, What: FOCIS 2008 ... June 4-Monday, June 9, Where: Boston Marriott Copley Place, ... that improves patient care, Wednesday, June 4, 8:30 ...
... with a certain type of prostate cancer have been ... plus prednisone in an international trial led by Oregon ... The research involved men with androgen-independent prostate cancer that ... prostate and is not longer responding to hormonal therapies. ...
... 16-0, in Favor of Short-Term Treatment of ... 30 GlaxoSmithKline (NYSE: GSK ),today ... Drug Administration,s,Oncology Drugs Advisory Committee (ODAC) unanimously ... risk-benefit profile for,the short-term treatment of patients ...
... HILL, N.C., May 30 Creating an effective ... a new product,s introduction.,A product,s promotion relies heavily ... benchmark companies ensure that they create effective, cross-functional,teams ... a new product., The detailed report provides ...
Cached Medicine News:Health News:Rotigotine Skin Patch May Ease Restless Legs Symptoms 2Health News:Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex 2Health News:Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex 3Health News:World-Renowned Scientists to Lead Immunology Course 2Health News:World-Renowned Scientists to Lead Immunology Course 3Health News:World-Renowned Scientists to Lead Immunology Course 4Health News:OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 3Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 4Health News:Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence 2
(Date:11/26/2014)... 2014  Cohen, Placitella & Roth, PC is ... purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... January 31, 2011 through November 2, 2014 ("Class ... of its officers and directors publically disseminated materially ... 10(b) and 20(a) of the Securities Exchange Act ...
(Date:11/26/2014)... 26, 2014  Over 100 million adults suffer from ... this pain daily. Chronic and acute pain dramatically impacts ... born to fulfill the need for non-surgical, interventional solutions ... On October 28th, a new pain management ... Maryland community.  This new facility boasts cutting ...
(Date:11/26/2014)... 2014 Zynerba Pharmaceuticals , Inc., a ... transdermal synthetic cannabinoid treatments, today announced that the company ... Conference 2014. The conference will be held December 2 ... New York . Zynerba,s Chairman and CEO, ... on Tuesday, December 2. To listen to ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
Validated by decades of research and clinical experience, HFA is the accepted standard of care in glaucoma diagnosis and management. With HFA you can feel confident you're providing the best possible...
... Rapidlab 1200's speed and accuracy allow ... in a timely manner - something ... especially patients. In fact, the Rapidlab ... in just one minute. Its maintenance-free, ...
... challenges. One complete solution. , Increased requirements ... Staff turnover. These are just some of ... challenges that can impact the amount of ... , , You can't afford ...
Dornier Holmium Laser for Urological Procedures...
Medicine Products: